Search:
|
|
|
 |
|
 |
| |
| April 3, 2012 (Tuesday) |
| 10 a.m. |
| Introduction |
| Overview |
| One person's perspective on the neurobiology of disease; Clinical info gathering |
| Gary Westbrook, Senior Scientist, Vollum Institute; Professor, Neurology, OHSU |
| This introductory session will outline the goals and structure of the
course, and establish the expectations for students in the course. We will
also overview some of the common mechanisms that cross disease boundaries
in neurological and psychiatric disease. In the second part of the session,
we will discuss how clinicians assess the nervous system and the diagnostic
steps necessary to define the part of the nervous system affected
(AKA "where's the lesion"), and then determine the underlying pathological
process. We will discuss how a working clinical diagnosis compares to
research criteria necessary for experimental studies, and how that impacts
studies of underlying mechanisms and potential therapies. We will use
clinical vignettes as part of the discussion. |
- What is the distinction between disease-oriented research and
translational research?
- Describe a typical pathway from basic observation to clinical therapy.
- Neurologists often approach clinical problems by trying to
determine "where's the lesion?" What does this mean?
- What components of nervous system function can be assessed in
the neurological exam?
- How would you define a "disease" for the purposes of an
experimental protocol or clinical trial?
|
| |
- Groopman, Jerome "What's the trouble?"
The New Yorker, January 29, 2007
- NOD Case 1 and 2
- Zoghbi et all 2000 "Neurobiology of disease"
|
- http://www.ohsu.edu/edcomm/flash/flash_player.php?params=1%60/sch/neus/626-040312.flv%60vod&width=640&height=480&title=NEUS%20626%2C%2004/03/12
|
|
|
 |
|
 |
|